IMU
IMUGENE LIMITED
$0.0370
▼ -5.13%
Market cap
$20M
Turnover
$282,816
Last price
$0.0370
Day change
-5.13%
Announcements
15
Range, past year
Open 0.410 · Low 0.010 · Now 0.037 · High 0.460
Open IMU in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
IMU momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-10-13.
Momentum quality
35/100
Wyckoff phase
Accumulation2d
Trend stage
Neutral
1 Day
-5.1%
1 Week
-9.8%
1 Month
-30.2%
1 Year
-90.5%
RSI
27
Avg daily range
10.7%
IMUGENE LIMITED scores 35 out of 100 for momentum quality, a reading rated low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Neutral.
On the Wyckoff cycle it sits in Accumulation, where it has been for 2 trading days. The weekly timeframe reads Downtrend, which does not yet agree with the daily view.
Against the wider market it is currently underperforming and the institutional accumulation signal reads low.
What stands out
- Trend R² 0.95 — highly linear uptrend
Points to watch
- RSI oversold (27)
- 60d drawdown -60.2%
- High volatility (ATR 10.7%)
- Risk rating: Very High
- Composite downside risk elevated
IMU announcements
Recent price-sensitive releases.
- 2026-10-05 azer-cel BTKi Cohort Reports new Complete & Partial Response Progress Report
- 2026-08-28 Appendix 4E and Annual Report Annual Report | Top 20 shareholders | Preliminary Final Report | Full Year Accounts | Full Year Audit Review | Full Year Directors' Statement | Full Year Directors' Report
- 2026-07-31 Quarterly Activities/Appendix 4C Cash Flow Report Commitments Test Entity - Fourth Quarter Activity Report | Commitments Test Entity - Fourth Quarter Cashflow Report
- 2026-07-27 Third response in concurrent BTKi Cohort of azer-cel Trial Progress Report
- 2026-07-27 CEO Resignation CEO/Managing Director - Appointment Resignation
- 2026-07-07 $11.1 Million Placement Completed to Advance azer-cel
- 2026-07-03 Trading Halt
More Health Care stocks
Most traded in the same sector.